Holen Sie sich die Stockscreener-App
6.35
0.47%
-0.03
Schlusskurs vom Vortag:
$6.38
Offen:
$6.16
24-Stunden-Volumen:
13,944
Relative Volume:
0.34
Marktkapitalisierung:
$37.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-71.07M
KGV:
-12.96
EPS:
-0.49
Netto-Cashflow:
$-63.98M
1W Leistung:
-10.69%
1M Leistung:
-42.27%
6M Leistung:
+12.79%
1J Leistung:
-23.25%
1-Tages-Spanne:
$6.16
$6.63
1-Wochen-Bereich:
$5.555
$7.2543
52-Wochen-Spanne:
$4.2701
$19.00
Vicarious Surgical Inc Stock (RBOT) Company Profile
Firmenname
Vicarious Surgical Inc
Sektor
Branche
Telefon
(617) 868-1700
Adresse
78 FOURTH AVENUE, WALTHAM
Vergleichen Sie RBOT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
6.62 | 37.84M | 0 | -71.07M | -63.98M | -0.49 |
|
ABT
Abbott Laboratories
|
131.62 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.58 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
374.08 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.55 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.03 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Vicarious Surgical Inc Stock (RBOT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Eingeleitet | Credit Suisse | Outperform |
| 2021-12-07 | Eingeleitet | Cowen | Outperform |
| 2021-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-10-18 | Eingeleitet | BTIG Research | Buy |
| 2021-10-07 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Vicarious Surgical Inc Aktie (RBOT) Neueste Nachrichten
Vicarious Surgical President Randy Clark to Become Board Member - MPO-mag
Learn to Evaluate (RBOT) using the Charts - news.stocktradersdaily.com
Vicarious Surgical President Randy Clark to Transition to Board Member - citybiz
Vicarious Surgical president shifts to board role By Investing.com - Investing.com South Africa
Vicarious surgical CEO sells $1,275 in stock By Investing.com - Investing.com Australia
Vicarious Surgical Announces President Transition to Board Member Role - Ortho Spine News
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock By Investing.com - Investing.com Canada
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock - Investing.com
Vicarious surgical CEO sells $1,275 in stock - Investing.com
Vicarious Surgical president shifts to board role - Investing.com India
Vicarious Surgical announces president transition to board member role -March 24, 2025 at 04:31 pm EDT - MarketScreener
Strategic Leadership Shift: Vicarious Surgical President Elevates to Board Role After Key Achievements - Stock Titan
Vicarious Faces Another Delay for FDA Submission - MD+DI
Vicarious Surgical Inc (NYSE:RBOT) Sees Significant Growth in Short Interest - Defense World
Monogram robot wins FDA OK; Vicarious hit by supplier woes - MedTech Dive
Vicarious Surgical’s Earnings Call: Achievements and Challenges - TipRanks
Piper Sandler cuts Vicarious Surgical stock target to $8.50 By Investing.com - Investing.com Australia
Piper Sandler cuts Vicarious Surgical stock target to $8.50 - Investing.com India
BTIG maintains Neutral on Vicarious Surgical stock post-results By Investing.com - Investing.com Australia
BTIG maintains Neutral on Vicarious Surgical stock post-results - Investing.com
Vicarious Surgical Inc. (NYSE:RBOT) Q4 2024 Earnings Call Transcript - MSN
Vicarious Surgical reports net loss of USD 14.4M in Q4 2024 - Medical Buyer
Vicarious Surgical Inc (RBOT) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Cost ... By GuruFocus - Investing.com Canada
Vicarious Surgical Reports 2024 Financial Results and Progress - TipRanks
Earnings call transcript: Vicarious Surgical Q4 2024 financials and outlook - Investing.com
Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial Results - OrthoSpineNews
Earnings call transcript: Vicarious Surgical Q4 2024 financials and outlook By Investing.com - Investing.com Australia
Vicarious Surgical Inc. SEC 10-K Report - TradingView
Vicarious Surgical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Vicarious Surgical Names Sarah Romano as Finance Chief - MPO-mag
Vicarious Surgical names Sarah Romano as CFO - Medical Buyer
Vicarious Surgical (RBOT) Projected to Post Quarterly Earnings on Monday - The AM Reporter
(RBOT) Trading Report - news.stocktradersdaily.com
Vicarious Surgical Inc expected to post a loss of $2.69 a shareEarnings Preview - TradingView
Vicarious Surgical appoints Sarah Romano as CFO - MedTech Dive
Vicarious Surgical Appoints Sarah Romano as Chief Financial Officer - citybiz
Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer - OrthoSpineNews
Vicarious Surgical appoints Sarah Romano as CFO -March 13, 2025 at 10:22 am EDT - Marketscreener.com
Vicarious Surgical names Sarah Romano as new CFO - Investing.com India
Vicarious Surgical Appoints New Chief Financial Officer - TipRanks
Vicarious Surgical names Sarah Romano as new CFO By Investing.com - Investing.com South Africa
Vicarious Surgical Names Sarah Romano Finance Chief -March 13, 2025 at 08:54 am EDT - Marketscreener.com
Vicarious Surgical (RBOT) Expected to Announce Quarterly Earnings on Monday - Defense World
Vicarious Surgical CEO Adam Sachs sells $5,499 in stock - Investing.com India
Vicarious Surgical CEO Adam Sachs sells $5,499 in stock By Investing.com - Investing.com South Africa
Vicarious surgical COO sells $2,713 in stock - Investing.com
Finanzdaten der Vicarious Surgical Inc-Aktie (RBOT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):